Latest filing published 02 Jul 2026 for IRLAB Therapeutics AB, €5,629.
Insider track record
No signal scores available.
Carola Elisabet Lemne: trading record in brief
Carola Elisabet Lemne is a declared insider of IRLAB Therapeutics AB, with filings sourced from Finansinspektionen. Over a trading history stretching from 25 February 2020 to 1 July 2026, the count stands at 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 2 July 2026: a transaction of €5,629, in IRLAB Therapeutics AB. The median gap between a trade and its publication by Finansinspektionen is 2 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Carola Elisabet Lemne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 52,333 shares@ SEK 1.2027.9% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-c6e5dad78154c1e4dd97
- 31,000 shares@ SEK 1.2016.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-d7e8a96b42391e08e898
- 36,000 shares@ SEK 3.5055.7% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003R127-1
- 1,000 shares@ SEK 27.0011.2% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-29f6c5e23e0cb1f9e22a
4 of 4 declarations